Skip to main content

ivermectin

Generic: IVERMECTIN·Brand: Agrimectin, Bimectin, Bimectin Plus, DuraMectin, Equimax, Heartgard Plus, IVERMECTIN, Iverhart, Iverhart Plus, Ivermax, Ivermax Plus, Ivomec, Ivomec Plus, Noromectin, Noromectin Plus, Prazimectin, Privermectin, Promectin, SKLICE, SOOLANTRA, STROMECTOL, Sklice, Soolantra, Stromectol, Tri-Heart Plus, Vetrimec, Vetrimec Plus, Zimecterin, Zimecterin Gold

ivermectin: 3 clinical trials tracked.

ivermectin evidence translation

What we can confirm

3 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about ivermectin, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 0 study sponsors

Related indications

COVID-19

Study sponsors

No additional listed-company sponsor is linked.

Clinical Trial Registry Records (3)

A Phase I/II Study Evaluating the Safety and Efficacy of Ivermectin in Combination With Immune Checkpoint Inhibitor in Patients With Metastatic Triple Negative Breast Cancer

NCT05318469Registry updated 2026-08-05·Phase 1/Phase 2
Recruiting

Primary endpoint: Incidence of adverse events

Interventionalopen34 targetStarted 2023-10Completion 2026-101 site · United StatesYuan Yuan

Finding Treatments for COVID-19: A Phase 2 Multi-centre Adaptive Platform Trial to Assess Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)

NCT05041907Registry updated 2026-02-19·Phase 2
Recruiting

Primary endpoint: Rate of viral clearance for interventions relative to the no study arm (This is a superiority comparison)

InterventionalRandomizedopen3,800 targetStarted 2021-09Completion 2027-017 sites · Brazil, Laos, Nepal, Pakistan…University of Oxford

COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)

NCT04510194Registry updated 2026-04-24·Phase 3
Completed

Primary endpoint: Clinical Progression to Severe Covid

InterventionalRandomizedquadruple1,323 enrolledStarted 2021-01Completion 2022-127 sites · United StatesUniversity of Minnesota